On July 23, 2025, Predictive Oncology Inc. was granted an extension until December 8, 2025, by Nasdaq to meet the minimum listing requirements after failing to maintain stockholders’ equity and bid price compliance. The company has ongoing actions to satisfy these requirements, but future compliance is uncertain.